Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis
DELISTED
What happened to Crinetics Pharmaceuticals, Inc. (CRNX) stock?
Crinetics Pharmaceuticals, Inc. (CRNX) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
Market cap $9.00B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Crinetics Pharmaceuticals, Inc. (CRNX). Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery and development of therapeutics for rare endocrine diseases and endocrine-related tumors.
Last analyzed: Jun 13, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
Crinetics Pharmaceuticals, Inc. (CRNX) Healthcare & Pipeline Overview
More about this archive record
Can I still buy CRNX shares?
No. CRNX stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for CRNX elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before CRNX stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Crinetics Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.